About SQI Diagnostics
SQI Diagnostics is a company based in Toronto (Canada) founded in 1999. SQI Diagnostics has completed 1 acquisition, including Precision Biomonitoring. SQI Diagnostics operates in a competitive market with competitors including Curative, Oxford Immunotec, HYCOR BioMedical, Exagen and Pictor, among others.
- Headquarter Toronto, Canada
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$744.82 K (USD), Post-IPO
Dec 02, 2022
- Investors
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of SQI Diagnostics
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of SQI Diagnostics
Investors in SQI Diagnostics
SQI Diagnostics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Wallmine.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Stocks charting and screening solutions are offered to users.
|
Locked | Locked | Locked |
Investor details for SQI Diagnostics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by SQI Diagnostics
SQI Diagnostics has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Precision Biomonitoring.
Investment portfolio details for SQI Diagnostics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Molecular diagnostic solutions are provided for organism detection in environments.
|
Locked | Locked | 2016 | Locked |
Complete acquisition details for SQI Diagnostics
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - SQI Diagnostics
Detailed financials for SQI Diagnostics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Sqi Diagnostics Comparisons
Peer comparison for SQI Diagnostics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of SQI Diagnostics
SQI Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Curative, Oxford Immunotec, HYCOR BioMedical, Exagen and Pictor, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Curative is recognized for providing affordable employer-sponsored health insurance.
|
|
| Locked | Locked | Locked |
Immune markers are utilized by Oxford Immunotec for disease diagnostics.
|
|
| Locked | Locked | Locked |
Developer of diagnostic instruments and reagents for autoimmune diseases and allergies
|
|
| Locked | Locked | Locked |
Diagnostic and monitoring solutions for autoimmune connective diseases are developed.
|
|
| Locked | Locked | Locked |
Immunodiagnostic products are developed via multiplexed assays.
|
|
| Locked | Locked | Locked |
Transfusion and transplantation diagnostic products are provided by Immucor.
|
Detailed competitors of SQI Diagnostics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sqi Diagnostics
Complete news archive for SQI Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SQI Diagnostics
SQI Diagnostics was founded in 1999 and raised its 1st funding round 18 years after it was founded.
SQI Diagnostics is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.
SQI Diagnostics was founded in 1999 and is headquartered in Toronto, Canada. Operations focus on the biotechnology and diagnostics sector, where proprietary Ig_plex technology is utilized to enable simultaneous automated analyses of multiple biomarkers at the isotype and subclass levels for laboratories and clinical research organizations. Key products include RALI-dx tests for COVID-19 severity triage, home testing kits, and diagnostics for lung inflammation.
SQI Diagnostics has made 1 acquisition, including Precision Biomonitoring.
SQI Diagnostics has 1 investor. Key investors include Wallmine.